Skip to main content
Fig. 2 | Health and Quality of Life Outcomes

Fig. 2

From: Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias

Fig. 2

Response frequencies at week 2 (start of treatment) and end of treatment by treatment arm from the mSICT adherence domains, a Thinking about stopping medication, b How hard/easy to take the medication, c Time to prepare medication, d Waiting time to eat, e Following doctor’s instructions, and f Trouble remembering to take medication. Numbers indicate the number of patients in each response category; *n < 5 patients. DT, dispersible tablet; FCT, film-coated tablet; mSICT, modified Satisfaction with Iron Chelation Therapy

Back to article page